Dana-Farber/New Hampshire Oncology-Hematology
Managing and Interpreting Cancer Risk
Considerations for Genetic Counseling and Testing
Monday, October 15, 2012
5:30 – 7:45 pm
Dana-Farber/New Hampshire Oncology-Hematology
Please join us for an evening seminar focused on evaluating and managing cancer risk through genetic counseling and testing. This course has been developed for primary care physicians, gynecologists, gastroenterologists, hematologists/oncologists, surgeons, nurse practitioners, and other interested clinicians. Faculty will present updates that will help physicians:
- Understand and describe the basic components of a genetic counseling consultation and what a patient can expect when referred for genetic counseling
- Identify potential risks, benefits, and limitations of genetic testing for inherited cancer syndromes
- Understand and explain the most common hereditary cancer predispositions
- Learn the features of a patient’s personal or family history that indicate a hereditary cancer syndrome or increased risk
- Recognize current recommendations for screening and risk reduction for breast, ovarian, and gastrointestinal cancers
This course is offered by Dana-Farber/New Hampshire Oncology-Hematology and Southern New Hampshire Area Health Education Center.
Registration
This course is free for interested providers. Space is limited.
To register, contact Carla LaPorte by October 10.
Email: carla_laporte@dfci.harvard.edu
Phone: 603-552-9125
Agenda
5:30 pm
Dinner and Networking
6:00 pm
Welcome
Frederick M. Briccetti, MD
6:10 pm
Introductions
Judy E. Garber, MD, MPH
6:20 pm
Hereditary Gastrointestinal Cancer Syndromes
Matthew B. Yurgelun, MD
6:45 pm
Hereditary Breast and Ovarian Cancer
Huma Q. Rana, MD
7:10 pm
Cancer Genetic Counseling: Indications for Referral and Implications of Testing
Claire Healy, MS, CGC
7:35 pm
Concluding Remarks
Frederick M. Briccetti MD and Judy E. Garber, MD, MPH
Faculty
Frederick M. Briccetti, MD
Medical Director, Dana-Farber/New Hampshire Oncology-Hematology;
Instructor in Medicine, Harvard Medical School
Judy E. Garber, MD, MPH
Director, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute;
Professor of Medicine, Harvard Medical School
Claire Healy, MS, CGC
Genetics Counselor, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Huma Q. Rana, MD
Medical Geneticist, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute;
Instructor in Medicine, Harvard Medical School
Matthew B. Yurgelun, MD
Medical Oncologist, Gastrointestinal Oncology Center and Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute;
Instructor in Medicine, Harvard Medical School
Accreditation
The Southern NH Area Health Education Center, accredited by the NH Medical Society, designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Southern NH Area Health Education Center is approved as a provider of continuing education in nursing by the New Hampshire Nurses’ Association Commission on Continuing Education which is accredited as an approver of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This continuing education activity has been approved for 1.25 contact hours. SNHAHEC Activity Number: 1064